Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
26.63
0.00 (0.00%)
Jun 10, 2025, 1:06 PM - Market open

Palvella Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
75.6383.67.3516.05
Cash & Short-Term Investments
75.6383.67.3516.05
Cash Growth
928.92%1037.44%-54.21%-
Accounts Receivable
-0.36--
Other Receivables
1.981.98--
Receivables
1.982.34--
Prepaid Expenses
1.842.30.20.47
Total Current Assets
79.4488.237.5516.52
Total Assets
79.4488.237.5516.52
Accounts Payable
4.444.590.943.18
Accrued Expenses
1.744.291.262.44
Other Current Liabilities
2.83.170.170.16
Total Current Liabilities
8.9812.042.365.78
Long-Term Debt
13.1611.948.0532.42
Other Long-Term Liabilities
1.721.651.011.5
Total Liabilities
23.8625.6311.4339.7
Common Stock
0.010.01--
Additional Paid-In Capital
157.49156.331.821.22
Retained Earnings
-101.92-93.74-76.3-94.99
Comprehensive Income & Other
-00--
Total Common Equity
55.5862.61-74.48-93.78
Shareholders' Equity
55.5862.61-3.88-23.17
Total Liabilities & Equity
79.4488.237.5516.52
Total Debt
13.1611.948.0532.42
Net Cash (Debt)
62.4771.66-0.7-16.36
Net Cash Per Share
13.7732.19-0.39-2.86
Filing Date Shares Outstanding
11.0611.025.725.72
Total Common Shares Outstanding
11.0211.015.725.72
Working Capital
70.4676.25.1910.74
Book Value Per Share
5.045.69-13.02-16.40
Tangible Book Value
55.5862.61-74.48-93.78
Tangible Book Value Per Share
5.045.69-13.02-16.40
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q